CC
CC.US Chemours Co
- Market cap
- USD 2.00B
- P/E
- -
- P/B
- 12.96x
- ROE
- -92.0%
- Dividend yield
- 3.90%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CC.US undervalued?
Graham numberThe Graham number of Chemours Co cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Chemours Co fundamental analysis
No fundamental analysis for Chemours Co yet.
Chemours Co stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Chemours Co
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Tita…
Full company profileChemours Co financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Chemours Co annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.40B | 6.18B | 6.64B | 5.53B | 4.97B | 6.35B | 6.83B | 6.08B | 5.78B | 5.81B | 6.02B |
| Gross Profit | 1.11B | 1.75B | 1.97B | 1.06B | 1.07B | 1.38B | 1.62B | 1.31B | 1.15B | 902M | 976M |
| Operating Income | 96.0M | 1.07B | 1.23B | 447M | 448M | 674M | 786M | -123M | 443M | -5.00M | 107M |
| EBITDA | 715M | 1.35B | 1.54B | 758M | 767M | 1.18B | 1.20B | 197M | 692M | 332M | 109M |
| Net Income | 7.00M | 746M | 995M | -52.0M | 219M | 608M | 578M | -238M | 86.0M | -386M | -143M |
| EPS | 0.04 | 3.91 | 5.45 | -0.32 | 1.32 | 3.60 | 3.65 | -1.60 | 0.57 | -2.56 | -0.94 |
| Balance Sheet | |||||||||||
| Total Assets | 6.06B | 7.29B | 7.36B | 7.26B | 7.08B | 7.55B | 7.64B | 8.25B | 7.52B | 7.38B | 7.29B |
| Total Liabilities | 5.96B | 6.43B | 6.34B | 6.56B | 6.27B | 6.47B | 6.53B | 7.51B | 6.91B | 7.13B | 7.14B |
| Shareholders' Equity | 100M | 860M | 1.01B | 689M | 813M | 1.08B | 1.11B | 737M | 604M | 250M | 155M |
| Cash & Short-term Investments | 902M | 1.56B | 1.20B | 943M | 1.11B | 1.45B | 1.10B | 1.20B | 713M | 672M | 698M |
| Total Debt | 3.54B | 4.11B | 3.97B | 4.47B | 4.28B | 3.99B | 3.88B | 4.30B | 4.36B | 4.59B | 4.03B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 594M | 639M | 1.14B | 650M | 807M | 820M | 754M | 556M | -633M | 264M | 351M |
| Capital Expenditure | 338M | 411M | 498M | 481M | 267M | 277M | 307M | 370M | 360M | 213M | 192M |
| Free Cash Flow | 256M | 228M | 642M | 169M | 540M | 543M | 447M | 186M | -993M | 51.0M | 159M |
| Ratios | |||||||||||
| ROE | 7.0% | 86.7% | 98.1% | -7.5% | 26.9% | 56.2% | 52.2% | -32.3% | 14.2% | -154.4% | -92.0% |
| ROA | 0.1% | 10.2% | 13.5% | -0.7% | 3.1% | 8.1% | 7.6% | -2.9% | 1.1% | -5.2% | -2.0% |
| Net Profit Margin | 0.1% | 12.1% | 15.0% | -0.9% | 4.4% | 9.6% | 8.5% | -3.9% | 1.5% | -6.6% | -2.4% |
| Debt to Equity | 35.44x | 4.78x | 3.92x | 6.49x | 5.26x | 3.69x | 3.50x | 5.83x | 7.21x | 18.34x | 25.97x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Chemours Co dividends
- Dividend yield
- 3.90%
- Forward dividend
- 0.35 USD
- Payout ratio
- -
- Ex-dividend date
- Nov 16, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 78.0M | 0.52 | - |
| 2024 | USD 148M | 0.99 | 172.1% |
| 2023 | USD 149M | 1.00 | - |
| 2022 | USD 154M | 0.97 | 26.6% |
| 2021 | USD 164M | 0.97 | 27.0% |
| 2020 | USD 164M | 0.99 | 74.9% |
| 2019 | USD 164M | 1.00 | - |
| 2018 | USD 148M | 0.81 | 14.9% |
| 2017 | USD 22.0M | 0.12 | 2.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Chemours Co
- Insiders 0.76%
- Institutions 84.30%
- Public & others 14.94%
- Shares outstanding 151M
- Free float 150M
Top funds holding CC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 9.07M | 6.02% | +0.06% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.82M | 3.20% | +0.39% | Sep 2026 |
| iShares Russell 2000 ETF | 3.91M | 2.60% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 3.39M | 2.25% | -2.00% | Sep 2026 |
| Columbia Select Mid Cap Value Instl | 2.33M | 1.55% | +2.13% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 2.20M | 1.46% | +0.33% | Sep 2026 |
| JPMorgan Large Cap Value I | 1.96M | 1.30% | -4.76% | Sep 2026 |
| Fidelity Small Cap Index | 1.70M | 1.13% | +0.89% | Aug 2026 |
| Avantis US Small Cap Value ETF | 1.69M | 1.12% | 0.00% | Oct 2026 |
| iShares Russell 2000 Growth ETF | 1.44M | 0.96% | -0.38% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 1.38M | 0.92% | -0.05% | Oct 2026 |
| iShares S&P Small-Cap 600 Value ETF | 1.25M | 0.83% | 0.00% | Oct 2026 |
| JPMorgan Active Value ETF | 1.14M | 0.76% | +0.22% | Oct 2026 |
| T. Rowe Price Small-Cap Value | 1.12M | 0.75% | +5.98% | Sep 2026 |
| Vanguard Tax-Managed Small Cap Adm | 1.09M | 0.73% | 0.00% | Sep 2026 |
| CREF Total Global Stock Account R3 | 959K | 0.64% | -2.57% | Aug 2026 |
| Vanguard Russell 2000 ETF | 894K | 0.59% | +1.14% | Sep 2026 |
| State Street® SPDR® S&P 600™ Sm CpValETF | 818K | 0.54% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 795K | 0.53% | +0.24% | Oct 2026 |
| Columbia Small Cap Value Discv A | 739K | 0.49% | +0.72% | Sep 2026 |
Top institutions holding CC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 23.3M | 15.47% | +4.01% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 10.6M | 7.02% | +2.36% | Jun 2026 |
| Vanguard Capital Management, LLC | 6.78M | 4.51% | +0.16% | Jun 2026 |
| State Street Corp | 6.12M | 4.06% | -0.13% | Jun 2026 |
| Ameriprise Financial Inc | 4.92M | 3.27% | +1.78% | Jun 2026 |
| American Century Companies Inc | 4.38M | 2.91% | -0.82% | Jun 2026 |
| JPMorgan Chase & Co | 4.20M | 2.79% | +10.49% | Jun 2026 |
| Geode Capital Management, LLC | 3.82M | 2.54% | +6.09% | Jun 2026 |
| Cooper Creek Partners Management LLC | 3.70M | 2.46% | +114.44% | Jun 2026 |
| VOYA INVESTMENT MANAGEMENT LLC | 3.54M | 2.36% | +8,329.13% | Jun 2026 |
| Wolf Hill Capital Management, LP | 2.91M | 1.93% | -21.15% | Jun 2026 |
| D. E. Shaw & Co LP | 2.87M | 1.91% | +0.67% | Jun 2026 |
| Highland Peak Capital LLC | 2.64M | 1.76% | +81.13% | Jun 2026 |
| UBS Group AG | 2.59M | 1.72% | -6.29% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 2.56M | 1.70% | -7.47% | Sep 2026 |
| The Goldman Sachs Group Inc | 2.55M | 1.70% | -15.32% | Jun 2026 |
| Charles Schwab Investment Management Inc | 2.04M | 1.36% | -5.07% | Jun 2026 |
| T. Rowe Price Investment Management,Inc. | 1.98M | 1.31% | +1.35% | Jun 2026 |
| Vision One Management Partners LP | 1.72M | 1.14% | 0.00% | Jun 2026 |
| Northern Trust Corp | 1.66M | 1.10% | +5.86% | Jun 2026 |
Chemours Co company profile
- Company name
- Chemours Co
- Ticker
- CC.US
- Exchange
- USA Stocks
- Listed since
- Jul 1, 2015
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 5,700
- Fiscal year end
- December
- Address
- 1007 Market Street, Wilmington, DE, United States, 19801
- Phone
- 302 773 1000
- Website
- chemours.com
About Chemours Co
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Chemours Co management
10- Ms. Denise M. DignamPresident, CEO & Director · born 1966
- Mr. Shane W. Hostetter CPASenior VP & CFO · born 1981
- Ms. Kristine M. WellmanSenior VP, General Counsel & Company Secretary · born 1970
- Mr. Gerardo Familiar CalderonPresident of Advanced Performance Materials · born 1977
- Mr. Joseph T. MartinkoPresident of Thermal & Specialized Solutions · born 1969
- Mr. David A. WillController & Chief Accounting Officer · born 1985
- Mr. Brandon OntjesVice President of Investor Relations
- Mr. Matthew J. ContiChief Human Resources Officer
- Mr. Aditya BeriInterim President of Titanium Technologies & Chemical Solutions Business
- Ms. Diane Iuliano PichoChief Enterprise Enablement Officer · born 1962